Asia Pacific Facial Injectable Market Size, Share & Industry Trends Analysis Report By End-use (MedSpa, Dermatology Clinics and Hospitals), By Product, By Application, By Country and Growth Forecast, 2023 - 2029

The Asia Pacific Facial Injectable Market would witness market growth of 11.1% CAGR during the forecast period (2023-2029).

With an anticipated strong increase during the projected period, the cosmetics sector is expected to continue its decade-long success. Since a few decades ago, non-surgical procedures have grown, including wrinkle relaxers and dermal filler injections. This evolution is primarily attributable to technology benefits, including quick healing, less blood loss, decreased infection risk, and cheaper overall treatment costs. Thus, during the projection period, the market expanded along with the rise in cosmetic procedures.

More eminent firms have joined the cosmetic injectables industry due to the promising developments in usage. To provide unique fillers that satisfy unmet consumer needs, these businesses have worked on several research & development projects. As a result, innovative products have been released, and procedure volumes have increased globally. Throughout the forecast period, these favorable aspects are anticipated to have a substantial impact on the growth of the market. Also, the rising use of these types of goods by people of all ages is another significant market trend that is anticipated to support the market's rise.

Given that China and India are two of the world's most populous nations, the region's elderly population is growing rapidly. India, the second-most populous country in the world, has experienced a dramatic demographic transition over the past 50 years, with the old population nearly tripling, according to the National Library of Medicine. The organization also estimated that by 2025, there would be 158.7 million elderly people in India and that by 2050, they would outnumber children under 14. The prevalence of fine lines, wrinkles, and other aging signs is predicted to increase considerably in the area with an increase in the older population. Because of this, it is anticipated that the market for facial injectables in the APAC region will expand throughout the projected period.

The China market dominated the Asia Pacific Facial Injectable Market by Country in 2022 thereby, achieving a market value of $1,726 Million by 2029. The Japan market is exhibiting a CAGR of 10.4% during (2023 - 2029). Additionally, The Taiwan market would experience a CAGR of 11.8% during (2023 - 2029).

Based on End-use, the market is segmented into MedSpa, Dermatology Clinics and Hospitals. Based on Product, the market is segmented into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Collagen & PMMA Microspheres, Hyaluronic Acid (HA) and Others. Based on Application, the market is segmented into Facial Line Correction, Face Lift, Lip Augmentation, Acne Scar Treatment, Lipoatrophy Treatment and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Taiwan, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Facial Injectable Market is Projected to reach USD 22.5 Billion by 2029, at a CAGR of 10.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Suneva Medical, Inc., Medytox Inc., Sinclair Pharma Ltd., Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group), Anika Therapeutics, Inc., Prollenium Medical Technologies Inc., Galderma S.A., and Allergan PLC (AbbVie, Inc.).

Scope of the Study

Market Segments Covered in the Report:

By End-use

• MedSpa
• Dermatology Clinics
• Hospitals

By Product

• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Poly-L-Lactic Acid (PLLA)
• Collagen & PMMA Microspheres
• Hyaluronic Acid (HA)
• Others

By Application

• Facial Line Correction
• Face Lift
• Lip Augmentation
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Taiwan
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Ipsen Pharma Biotech SAS
• Merz Pharma GmbH & Co. KGaA
• Suneva Medical, Inc.
• Medytox Inc.
• Sinclair Pharma Ltd.
• Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
• Anika Therapeutics, Inc.
• Prollenium Medical Technologies Inc.
• Galderma S.A.
• Allergan PLC (AbbVie, Inc.)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Facial Injectable Market, by End-use
1.4.2 Asia Pacific Facial Injectable Market, by Product
1.4.3 Asia Pacific Facial Injectable Market, by Application
1.4.4 Asia Pacific Facial Injectable Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Facial Injectable Market by End-use
3.1 Asia Pacific MedSpa Market by Country
3.2 Asia Pacific Dermatology Clinics Market by Country
3.3 Asia Pacific Hospitals Market by Country

Chapter 4. Asia Pacific Facial Injectable Market by Product
4.1 Asia Pacific Botulinum Toxin Type A Market by Country
4.2 Asia Pacific Calcium Hydroxylapatite (CaHA) Market by Country
4.3 Asia Pacific Poly-L-Lactic Acid (PLLA) Market by Country
4.4 Asia Pacific Collagen & PMMA Microspheres Market by Country
4.5 Asia Pacific Hyaluronic Acid (HA) Market by Country
4.6 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Facial Injectable Market by Application
5.1 Asia Pacific Facial Line Correction Market by Country
5.2 Asia Pacific Face Lift Market by Country
5.3 Asia Pacific Lip Augmentation Market by Country
5.4 Asia Pacific Acne Scar Treatment Market by Country
5.5 Asia Pacific Lipoatrophy Treatment Market by Country
5.6 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Facial Injectable Market by Country
6.1 China Facial Injectable Market
6.1.1 China Facial Injectable Market by End-use
6.1.2 China Facial Injectable Market by Product
6.1.3 China Facial Injectable Market by Application
6.2 Japan Facial Injectable Market
6.2.1 Japan Facial Injectable Market by End-use
6.2.2 Japan Facial Injectable Market by Product
6.2.3 Japan Facial Injectable Market by Application
6.3 Taiwan Facial Injectable Market
6.3.1 Taiwan Facial Injectable Market by End-use
6.3.2 Taiwan Facial Injectable Market by Product
6.3.3 Taiwan Facial Injectable Market by Application
6.4 India Facial Injectable Market
6.4.1 India Facial Injectable Market by End-use
6.4.2 India Facial Injectable Market by Product
6.4.3 India Facial Injectable Market by Application
6.5 South Korea Facial Injectable Market
6.5.1 South Korea Facial Injectable Market by End-use
6.5.2 South Korea Facial Injectable Market by Product
6.5.3 South Korea Facial Injectable Market by Application
6.6 Singapore Facial Injectable Market
6.6.1 Singapore Facial Injectable Market by End-use
6.6.2 Singapore Facial Injectable Market by Product
6.6.3 Singapore Facial Injectable Market by Application
6.7 Rest of Asia Pacific Facial Injectable Market
6.7.1 Rest of Asia Pacific Facial Injectable Market by End-use
6.7.2 Rest of Asia Pacific Facial Injectable Market by Product
6.7.3 Rest of Asia Pacific Facial Injectable Market by Application

Chapter 7. Company Profiles
7.1 Ipsen Pharma Biotech SAS
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.2 Merz Pharma GmbH & Co. KGaA
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.2.2.2 Product Launches and Product Expansions:
7.3 Suneva Medical, Inc.
7.3.1 Company Overview
7.4 Medytox Inc.
7.4.1 Company Overview
7.5 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Product Launches and Product Expansions:
7.5.2.2 Approvals and Trials:
7.6 Bloomage Biotechnology Corporation Limited (Bloomage International Investment Group)
7.6.1 Company Overview
7.7 Anika Therapeutics, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Prollenium Medical Technologies Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Acquisition and Mergers:
7.9 Galderma S.A.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.10. Allergan PLC (AbbVie, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense

TABLE 1 Asia Pacific Facial Injectable Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Facial Injectable Market, 2023 - 2029, USD Million
TABLE 3 Asia Pacific Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 5 Asia Pacific MedSpa Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific MedSpa Market by Country, 2023 - 2029, USD Million
TABLE 7 Asia Pacific Dermatology Clinics Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Dermatology Clinics Market by Country, 2023 - 2029, USD Million
TABLE 9 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 11 Asia Pacific Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 13 Asia Pacific Botulinum Toxin Type A Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Botulinum Toxin Type A Market by Country, 2023 - 2029, USD Million
TABLE 15 Asia Pacific Calcium Hydroxylapatite (CaHA) Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Calcium Hydroxylapatite (CaHA) Market by Country, 2023 - 2029, USD Million
TABLE 17 Asia Pacific Poly-L-Lactic Acid (PLLA) Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Poly-L-Lactic Acid (PLLA) Market by Country, 2023 - 2029, USD Million
TABLE 19 Asia Pacific Collagen & PMMA Microspheres Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Collagen & PMMA Microspheres Market by Country, 2023 - 2029, USD Million
TABLE 21 Asia Pacific Hyaluronic Acid (HA) Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Hyaluronic Acid (HA) Market by Country, 2023 - 2029, USD Million
TABLE 23 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 25 Asia Pacific Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 27 Asia Pacific Facial Line Correction Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Facial Line Correction Market by Country, 2023 - 2029, USD Million
TABLE 29 Asia Pacific Face Lift Market by Country, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Face Lift Market by Country, 2023 - 2029, USD Million
TABLE 31 Asia Pacific Lip Augmentation Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Lip Augmentation Market by Country, 2023 - 2029, USD Million
TABLE 33 Asia Pacific Acne Scar Treatment Market by Country, 2019 - 2022, USD Million
TABLE 34 Asia Pacific Acne Scar Treatment Market by Country, 2023 - 2029, USD Million
TABLE 35 Asia Pacific Lipoatrophy Treatment Market by Country, 2019 - 2022, USD Million
TABLE 36 Asia Pacific Lipoatrophy Treatment Market by Country, 2023 - 2029, USD Million
TABLE 37 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 38 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
TABLE 39 Asia Pacific Facial Injectable Market by Country, 2019 - 2022, USD Million
TABLE 40 Asia Pacific Facial Injectable Market by Country, 2023 - 2029, USD Million
TABLE 41 China Facial Injectable Market, 2019 - 2022, USD Million
TABLE 42 China Facial Injectable Market, 2023 - 2029, USD Million
TABLE 43 China Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 44 China Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 45 China Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 46 China Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 47 China Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 48 China Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 49 Japan Facial Injectable Market, 2019 - 2022, USD Million
TABLE 50 Japan Facial Injectable Market, 2023 - 2029, USD Million
TABLE 51 Japan Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 52 Japan Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 53 Japan Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 54 Japan Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 55 Japan Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 56 Japan Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 57 Taiwan Facial Injectable Market, 2019 - 2022, USD Million
TABLE 58 Taiwan Facial Injectable Market, 2023 - 2029, USD Million
TABLE 59 Taiwan Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 60 Taiwan Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 61 Taiwan Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 62 Taiwan Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 63 Taiwan Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 64 Taiwan Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 65 India Facial Injectable Market, 2019 - 2022, USD Million
TABLE 66 India Facial Injectable Market, 2023 - 2029, USD Million
TABLE 67 India Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 68 India Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 69 India Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 70 India Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 71 India Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 72 India Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 73 South Korea Facial Injectable Market, 2019 - 2022, USD Million
TABLE 74 South Korea Facial Injectable Market, 2023 - 2029, USD Million
TABLE 75 South Korea Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 76 South Korea Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 77 South Korea Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 78 South Korea Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 79 South Korea Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 80 South Korea Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 81 Singapore Facial Injectable Market, 2019 - 2022, USD Million
TABLE 82 Singapore Facial Injectable Market, 2023 - 2029, USD Million
TABLE 83 Singapore Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 84 Singapore Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 85 Singapore Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 86 Singapore Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 87 Singapore Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 88 Singapore Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 89 Rest of Asia Pacific Facial Injectable Market, 2019 - 2022, USD Million
TABLE 90 Rest of Asia Pacific Facial Injectable Market, 2023 - 2029, USD Million
TABLE 91 Rest of Asia Pacific Facial Injectable Market by End-use, 2019 - 2022, USD Million
TABLE 92 Rest of Asia Pacific Facial Injectable Market by End-use, 2023 - 2029, USD Million
TABLE 93 Rest of Asia Pacific Facial Injectable Market by Product, 2019 - 2022, USD Million
TABLE 94 Rest of Asia Pacific Facial Injectable Market by Product, 2023 - 2029, USD Million
TABLE 95 Rest of Asia Pacific Facial Injectable Market by Application, 2019 - 2022, USD Million
TABLE 96 Rest of Asia Pacific Facial Injectable Market by Application, 2023 - 2029, USD Million
TABLE 97 Key Information – Ipsen Pharma Biotech SAS
TABLE 98 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 99 Key Information – Suneva Medical, Inc.
TABLE 100 Key Information – Medytox Inc.
TABLE 101 Key Information – Sinclair Pharma Ltd.
TABLE 102 Key Information – Bloomage Biotechnology Corporation Limited
TABLE 103 Key Information – Anika Therapeutics, Inc.
TABLE 104 Key Information – Prollenium Medical Technologies Inc.
TABLE 105 Key Information – Galderma S.A.
TABLE 106 Key Information – Allergan PLC

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Facial Injectable Market Share by End-use, 2022
FIG 3 Asia Pacific Facial Injectable Market Share by End-use, 2029
FIG 4 Asia Pacific Facial Injectable Market by End-use, 2019 - 2029, USD Million
FIG 5 Asia Pacific Facial Injectable Market Share by Product, 2022
FIG 6 Asia Pacific Facial Injectable Market Share by Product, 2029
FIG 7 Asia Pacific Facial Injectable Market by Product, 2019 - 2029, USD Million
FIG 8 Asia Pacific Facial Injectable Market Share by Application, 2022
FIG 9 Asia Pacific Facial Injectable Market Share by Application, 2029
FIG 10 Asia Pacific Facial Injectable Market by Application, 2019 - 2029, USD Million
FIG 11 Asia Pacific Facial Injectable Market Share by Country, 2022
FIG 12 Asia Pacific Facial Injectable Market Share by Country, 2029
FIG 13 Asia Pacific Facial Injectable Market by Country, 2019 - 2029, USD Million
FIG 14 Recent strategies and developments: Merz Pharma GmbH & Co. KGaA